Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Open in API
Filings indexed 392 across all filing types
Latest filing 2020-10-06 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the period ended September 30, 2020. It is addressed to stock exchanges and signed by the company secretary. The content is a regulatory compliance certificate rather than a full financial report or announcement of financial results. The document length is short (1409 characters) and it primarily serves as a certification or confirmation letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as a financial report type.
2020-10-06 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notification to stock exchanges about an upcoming Board Meeting scheduled for October 29, 2020. The agenda includes approval of unaudited standalone and consolidated financial results for the half year ended September 30, 2020, and granting ESOPs to employees. This is a typical announcement of a board meeting and its agenda, not the actual financial results or report. The document is short (1388 characters) and serves as an intimation rather than containing substantive financial data or analysis. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of board meetings and related management decisions.
2020-09-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window due to insider trading regulations. It references the upcoming declaration of unaudited financial results for the half-year ended September 30, 2020, but does not contain any financial data or the results themselves. The document is short (1562 characters) and serves as a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a compliance notification.
2020-09-30 English
Financial Result Updates
Regulatory Filings
2020-07-30 English
Outcome of Board Meeting
Regulatory Filings
2020-07-30 English
Shareholders meeting
Regulatory Filings
2020-07-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.